What is the recommended treatment for a patient with bacterial conjunctivitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 12, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Bacterial Conjunctivitis

For mild bacterial conjunctivitis, prescribe a 5-7 day course of broad-spectrum topical antibiotic applied 4 times daily, choosing the most convenient or least expensive option since no evidence shows superiority of any particular agent. 1, 2

Initial Treatment Approach

Mild Cases

  • Apply broad-spectrum topical antibiotic 4 times daily for 5-7 days 3, 1, 2
  • Select the most convenient or least expensive option—clinical evidence does not demonstrate superiority of any particular antibiotic for uncomplicated cases 1, 2
  • Effective first-line options include:
    • Aminoglycosides (tobramycin, gentamicin) 3, 1
    • Polymyxin B/trimethoprim 1
    • Bacitracin (applied 1-3 times daily) 4
    • Erythromycin (up to 6 times daily depending on severity) 5

Moderate to Severe Cases

  • Reserve fluoroquinolones (moxifloxacin, gatifloxacin, ofloxacin, ciprofloxacin) for cases with copious purulent discharge, pain, and marked inflammation 1, 2
  • Obtain conjunctival cultures and Gram staining before initiating treatment 3, 1, 2
  • Fourth-generation fluoroquinolones (moxifloxacin, gatifloxacin) provide better gram-positive coverage, including some MRSA strains 1

Contact Lens Wearers

  • Use fluoroquinolones specifically due to higher risk of Pseudomonas infection 1

Special Populations Requiring Systemic Therapy

Gonococcal Conjunctivitis

  • Requires systemic antibiotic therapy—topical treatment alone is insufficient 3, 1, 2
  • Add saline lavage for comfort and faster resolution 1
  • Daily follow-up until resolution is mandatory 2

Chlamydial Conjunctivitis

  • Requires systemic antibiotic therapy, especially in infants who may have infection at other sites 3, 1, 2
  • For neonates: erythromycin base or ethylsuccinate 50 mg/kg/day divided into 4 doses for 14 days 1
  • No evidence supports adding topical therapy beyond systemic treatment 1
  • Treatment failure occurs in up to 19% of cases, requiring follow-up evaluation 2

MRSA Infections

  • May require compounded topical vancomycin since MRSA is resistant to most commercially available topical antibiotics including aminoglycosides and fluoroquinolones 1

Alternative When Antibiotic Access is Limited

  • Povidone-iodine 1.25% ophthalmic solution may be as effective as topical antibiotics and can be considered when access is limited 3, 1, 2

Follow-Up Protocol

  • Instruct patients to return if no improvement after 3-4 days of treatment 3, 1, 2
  • At follow-up, perform interval history, visual acuity measurement, and slit-lamp biomicroscopy 3, 1

Critical Pitfalls to Avoid

Do Not Use Topical Corticosteroids

  • Avoid topical corticosteroids unless under close ophthalmologic supervision—they may prolong bacterial shedding and worsen infection 3
  • Exception: brief course may be indicated for severe inflammation with baseline and periodic intraocular pressure monitoring 1

Do Not Prescribe Antibiotics for Viral Conjunctivitis

  • Avoid antibiotics for viral conjunctivitis—this creates unnecessary costs and promotes resistance 1

Consider Sexual Abuse

  • In children with gonococcal or chlamydial conjunctivitis, consider the possibility of sexual abuse 3, 1, 2

When to Refer to Ophthalmology

Immediate referral is indicated for: 3, 1

  • Visual loss
  • Moderate or severe pain
  • Severe purulent discharge
  • Corneal involvement
  • Conjunctival scarring
  • Lack of response to therapy
  • Recurrent episodes
  • Neonatal conjunctivitis (mandatory hospitalization) 1

Infection Control Measures

  • Counsel patients on frequent hand washing and avoiding sharing personal items to prevent spread 3, 1
  • Topical antibiotics reduce transmissibility and allow earlier return to school/work 1, 2

References

Guideline

Treatment of Bacterial Conjunctivitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Treatment of Bacterial Conjunctivitis: Frequency and Duration

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Infectious Conjunctivitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.